171 related articles for article (PubMed ID: 22682976)
1. The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice.
Luan Z; Li L; Higaki K; Nanba E; Suzuki Y; Ohno K
Brain Dev; 2013 Apr; 35(4):317-22. PubMed ID: 22682976
[TBL] [Abstract][Full Text] [Related]
2. The effect of N-octyl-β-valienamine on β-glucosidase activity in tissues of normal mice.
Luan Z; Ninomiya H; Ohno K; Ogawa S; Kubo T; Iida M; Suzuki Y
Brain Dev; 2010 Nov; 32(10):805-9. PubMed ID: 20074885
[TBL] [Abstract][Full Text] [Related]
3. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
4. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
Suzuki Y
Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N
Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960
[TBL] [Abstract][Full Text] [Related]
6. A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies.
Luan Z; Higaki K; Aguilar-Moncayo M; Li L; Ninomiya H; Nanba E; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2010 Nov; 11(17):2453-64. PubMed ID: 21064079
[TBL] [Abstract][Full Text] [Related]
7. A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease.
Thirumal Kumar D; Iyer S; Christy JP; Siva R; Tayubi IA; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2019; 114():315-339. PubMed ID: 30635084
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
Maegawa GH; Tropak MB; Buttner JD; Rigat BA; Fuller M; Pandit D; Tang L; Kornhaber GJ; Hamuro Y; Clarke JT; Mahuran DJ
J Biol Chem; 2009 Aug; 284(35):23502-16. PubMed ID: 19578116
[TBL] [Abstract][Full Text] [Related]
9. N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Lin H; Sugimoto Y; Ohsaki Y; Ninomiya H; Oka A; Taniguchi M; Ida H; Eto Y; Ogawa S; Matsuzaki Y; Sawa M; Inoue T; Higaki K; Nanba E; Ohno K; Suzuki Y
Biochim Biophys Acta; 2004 Aug; 1689(3):219-28. PubMed ID: 15276648
[TBL] [Abstract][Full Text] [Related]
10. Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
Lei K; Ninomiya H; Suzuki M; Inoue T; Sawa M; Iida M; Ida H; Eto Y; Ogawa S; Ohno K; Suzuki Y
Biochim Biophys Acta; 2007 May; 1772(5):587-96. PubMed ID: 17363227
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol.
Pantoom S; Hules L; Schöll C; Petrosyan A; Monticelli M; Pospech J; Cubellis MV; Hermann A; Lukas J
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408914
[TBL] [Abstract][Full Text] [Related]
12.
Ciana G; Dardis A; Pavan E; Da Riol RM; Biasizzo J; Ferino D; Zanatta M; Boni A; Antonini L; Crichiutti G; Bembi B
Mol Genet Metab Rep; 2020 Dec; 25():100678. PubMed ID: 33294373
[TBL] [Abstract][Full Text] [Related]
13. Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase.
Bendikov-Bar I; Maor G; Filocamo M; Horowitz M
Blood Cells Mol Dis; 2013 Feb; 50(2):141-5. PubMed ID: 23158495
[TBL] [Abstract][Full Text] [Related]
14. Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease.
Zimran A; Altarescu G; Elstein D
Blood Cells Mol Dis; 2013 Feb; 50(2):134-7. PubMed ID: 23085429
[TBL] [Abstract][Full Text] [Related]
15. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
[TBL] [Abstract][Full Text] [Related]
16. Conformationally-locked C-glycosides: tuning aglycone interactions for optimal chaperone behaviour in Gaucher fibroblasts.
Navo CD; Corzana F; Sánchez-Fernández EM; Busto JH; Avenoza A; Zurbano MM; Nanba E; Higaki K; Ortiz Mellet C; García Fernández JM; Peregrina JM
Org Biomol Chem; 2016 Jan; 14(4):1473-84. PubMed ID: 26690983
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
Khanna R; Benjamin ER; Pellegrino L; Schilling A; Rigat BA; Soska R; Nafar H; Ranes BE; Feng J; Lun Y; Powe AC; Palling DJ; Wustman BA; Schiffmann R; Mahuran DJ; Lockhart DJ; Valenzano KJ
FEBS J; 2010 Apr; 277(7):1618-38. PubMed ID: 20148966
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
Migdalska-Richards A; Daly L; Bezard E; Schapira AH
Ann Neurol; 2016 Nov; 80(5):766-775. PubMed ID: 27859541
[TBL] [Abstract][Full Text] [Related]
19. Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review.
Higashi K; Sonoda Y; Kaku N; Fujii F; Yamashita F; Lee S; Tocan V; Ebihara G; Matsuoka W; Tetsuhara K; Sonoda M; Chong PF; Mushimoto Y; Kojima-Ishii K; Ishimura M; Koga Y; Fukuta A; Tsuchihashi NA; Kikuchi Y; Karashima T; Sawada T; Hotta T; Yoshimitsu M; Terazono H; Tajiri T; Nakagawa T; Sakai Y; Nakamura K; Ohga S
Mol Genet Genomic Med; 2024 Apr; 12(4):e2427. PubMed ID: 38553911
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.
Luan Z; Li L; Ninomiya H; Ohno K; Ogawa S; Kubo T; Iida M; Suzuki Y
Blood Cells Mol Dis; 2010 Jan; 44(1):48-54. PubMed ID: 19857976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
